Literature DB >> 21397983

Quality of life in cutaneous lupus erythematosus.

Rachel Klein1, Siamak Moghadam-Kia, Lynne Taylor, Christopher Coley, Joyce Okawa, Jonathan LoMonico, Mary-Margaret Chren, Victoria P Werth.   

Abstract

BACKGROUND: Little is known about quality of life in patients with cutaneous lupus erythematosus.
OBJECTIVE: We sought to determine how cutaneous lupus affects quality of life and which independent variables are associated with poor quality of life.
METHODS: A total of 157 patients with cutaneous lupus completed surveys related to quality of life, including the Skindex-29 and the Short Form-36.
RESULTS: Quality of life in cutaneous lupus is severely impaired, particularly with respect to emotional well-being. Patients with cutaneous lupus have worse quality of life than those with other common dermatologic conditions, such as acne, nonmelanoma skin cancer, and alopecia. With respect to mental health status, patients with cutaneous lupus have similar or worse scores than patients with hypertension, type 2 diabetes mellitus, recent myocardial infarction, and congestive heart failure. Factors related to poor quality of life include female gender, generalized disease, severe disease, distribution of lesions, and younger age. LIMITATIONS: The study was done at a single referral-only center.
CONCLUSION: Patients with cutaneous lupus have very impaired quality of life, particularly from an emotional perspective.
Copyright © 2010 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21397983      PMCID: PMC3079065          DOI: 10.1016/j.jaad.2010.02.008

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  38 in total

1.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

2.  Association of dissatisfaction with care and psychiatric morbidity with poor treatment compliance.

Authors:  Cristina Renzi; Angelo Picardi; Damiano Abeni; Elisabetta Agostini; Giannandrea Baliva; Paolo Pasquini; Pietro Puddu; Mario Braga
Journal:  Arch Dermatol       Date:  2002-03

3.  Psychiatric symptoms in dermatology patients.

Authors:  J E Hughes; B M Barraclough; L G Hamblin; J E White
Journal:  Br J Psychiatry       Date:  1983-07       Impact factor: 9.319

4.  The contribution of perceptions of stigmatisation to disability in patients with psoriasis.

Authors:  H L Richards; D G Fortune; C E Griffiths; C J Main
Journal:  J Psychosom Res       Date:  2001-01       Impact factor: 3.006

5.  The classification of psychiatric morbidity in attenders at a dermatology clinic.

Authors:  S C Wessely; G H Lewis
Journal:  Br J Psychiatry       Date:  1989-11       Impact factor: 9.319

6.  Psychiatric morbidity in dermatological outpatients: an issue to be recognized.

Authors:  A Picardi; D Abeni; C F Melchi; P Puddu; P Pasquini
Journal:  Br J Dermatol       Date:  2000-11       Impact factor: 9.302

7.  Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey.

Authors:  R C Kessler; K A McGonagle; S Zhao; C B Nelson; M Hughes; S Eshleman; H U Wittchen; K S Kendler
Journal:  Arch Gen Psychiatry       Date:  1994-01

8.  Association between poorer quality of life and psychiatric morbidity in patients with different dermatological conditions.

Authors:  Francesca Sampogna; Angelo Picardi; Mary-Margaret Chren; C Franco Melchi; Paolo Pasquini; Cinzia Masini; Damiano Abeni
Journal:  Psychosom Med       Date:  2004 Jul-Aug       Impact factor: 4.312

9.  Recognition of depressive and anxiety disorders in dermatological outpatients.

Authors:  Angelo Picardi; Paolo Amerio; Giannandrea Baliva; Claudio Barbieri; Patrizia Teofoli; Simone Bolli; Valentina Salvatori; Eva Mazzotti; Paolo Pasquini; Damiano Abeni
Journal:  Acta Derm Venereol       Date:  2004       Impact factor: 4.437

10.  The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.

Authors:  C A McHorney; J E Ware; A E Raczek
Journal:  Med Care       Date:  1993-03       Impact factor: 2.983

View more
  55 in total

1.  Quality of life in dermatomyositis.

Authors:  Renato Goreshi; Monika Chock; Kristen Foering; Rui Feng; Joyce Okawa; Matt Rose; David Fiorentino; Victoria Werth
Journal:  J Am Acad Dermatol       Date:  2011-07-01       Impact factor: 11.527

Review 2.  Therapeutic options for cutaneous lupus erythematosus: recent advances and future prospects.

Authors:  Joshua Chang; Victoria P Werth
Journal:  Expert Rev Clin Immunol       Date:  2016-06-01       Impact factor: 4.473

3.  The impact of skin damage due to cutaneous lupus on quality of life.

Authors:  S M Verma; J Okawa; K J Propert; V P Werth
Journal:  Br J Dermatol       Date:  2014-02       Impact factor: 9.302

4.  Factors associated with quality of life in cutaneous lupus erythematosus using the Revised Wilson and Cleary Model.

Authors:  Motolani E Ogunsanya; Sung Kyung Cho; Andrew Hudson; Benjamin F Chong
Journal:  Lupus       Date:  2020-09-03       Impact factor: 2.911

5.  A multicentre, cross-sectional study on quality of life in patients with cutaneous lupus erythematosus.

Authors:  R Vasquez; D Wang; Q P Tran; B Adams-Huet; M-M Chren; M I Costner; J B Cohen; V P Werth; B F Chong
Journal:  Br J Dermatol       Date:  2012-09-13       Impact factor: 9.302

6.  Prevalence of self-report photosensitivity in cutaneous lupus erythematosus.

Authors:  Kristen Foering; Renato Goreshi; Rachel Klein; Joyce Okawa; Mathew Rose; Andrew Cucchiara; Victoria P Werth
Journal:  J Am Acad Dermatol       Date:  2011-07-13       Impact factor: 11.527

7.  Quality of life differences between responders and nonresponders in the treatment of cutaneous lupus erythematosus.

Authors:  Aileen Y Chang; Elizabeth Ghazi; Joyce Okawa; Victoria P Werth
Journal:  JAMA Dermatol       Date:  2013-01       Impact factor: 10.282

8.  Health-related quality of life in morphoea.

Authors:  N K Klimas; A D Shedd; I H Bernstein; H Jacobe
Journal:  Br J Dermatol       Date:  2015-04-08       Impact factor: 9.302

Review 9.  Photosensitivity in cutaneous lupus erythematosus.

Authors:  Andrew Kim; Benjamin F Chong
Journal:  Photodermatol Photoimmunol Photomed       Date:  2013-02       Impact factor: 3.135

10.  A cross-sectional study of untreated depression and anxiety in cutaneous lupus erythematosus and dermatomyositis.

Authors:  Jordan Achtman; Mitchel A Kling; Rui Feng; Joyce Okawa; Victoria P Werth
Journal:  J Am Acad Dermatol       Date:  2016-02       Impact factor: 11.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.